For citations:

Nasonov EL, Panasyuk EY, Nasonov EL, Panasyuk EY. USE OF THE NEW GENETIC ENGINEERING BIOLOGICAL AGENT TOCILIZUMABIN THE TREATMENT OF RHEUMATOID ARTHRITIS. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2010;4(1):59-61. (In Russ.) https://doi.org/10.14412/1996-7012-2010-588